| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $182.3M | — | +47.2% |
| Cost of Revenue | $28.1M | — | +19.0% |
| Gross Profit | $154.2M | — | +53.9% |
| R&D Expense | $30.3M | — | +29.1% |
| SG&A Expense | $23.0M | — | +36.4% |
| Operating Income | $32.1M | — | +144.1% |
| Pre-tax Income | $35.9M | — | +98.2% |
| Income Tax | $814K | — | -18.4% |
| Net Income | $35.1M | — | +105.0% |
| EPS (Basic) | $0.43 | — | -94.6% |
| EPS (Diluted) | $0.41 | — | -68.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $186.7M | -10.3% | -35.3% |
| Accounts Receivable | $114.9M | +74.0% | — |
| Inventory | $14.2M | -9.4% | — |
| Current Assets | $540.1M | +1.2% | — |
| Total Assets | $728.8M | -2.1% | — |
| Current Liabilities | $414.5M | +14.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $43.1M | — | +774.8% |
| Capital Expenditures | $83K | — | +62.7% |
| Investing Cash Flow | $48.1M | — | +325.4% |
| Financing Cash Flow | -$112.8M | — | -2849.7% |
| Free Cash Flow | $43.0M | — | +782.2% |
| — |
| Total Liabilities | $417.2M | +13.9% | — |
| Stockholders' Equity | $111.7M | -37.5% | +136.2% |